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SDS selection
Findings
• After washing off a bit over 100 plates, and exposing 
the worms to SDS, we found 7 independent mutants 
that suppressed their dex-1 phenotype.
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Project Outline
Our project set out to find potential interactors of dex-1
during dauer by conducting a suppressor screen
Suppressor Screening
• We started by finding dex-1 mutants that’ve 
suppressed their SDS sensitivity, and we did this 
through mutagenesis and SDS selection. 
• This involved mutating dex-1 mutants with EMS, and 
exposing their F2 progeny to SDS while in dauer. We 
then moved on to mapping the survivors mutation. 
Gene Mapping
• Once we isolate suppressor mutants, we will perform 
several crosses between these mutants and 
mapping strains. 
• Based on the crosses progeny's phenotypic ratios, 
these crosses will tell us what chromosome the 
mutated gene lies on, and further crosses will narrow 
down and eventually determine the map position. 
• After finding that position, we will track the new gene’s 
resulting protein and its effect. 
Mutagenesis
Background
C. elegans:
• Caenorhabditis elegans is a species of microscopic round 
worm that has been used as a genetic model for over forty 
years. 
• When in an adverse environment, C. elegans larvae cease 
reproductive development and enter the stress-resistant 
dauer stage1 (Fig.2).
• The focus of our lab is characterizing the genetic 
pathways that facilitate morphological changes that occur 
during the dauer stage.
dex-1 mutants
dex-1 mutants of C. elegans:
• DEX-1 is an extracellular matrix protein in C. elegans 
responsible for proper dendrite morphology in the early 
stages of the worms growth.2
• dex-1 mutants are deficient in this protein, resulting in 
shortened dendrites and a sensitivity to sodium dodecyl 
sulfate (SDS).
• SDS will kill any non-dauer C. elegans, but wild type 
dauers will survive well past the standard concentration of 
1% SDS. Thus, treatment with SDS is commonly how labs 
isolate dauers. 
• In contrast, dex-1 dauers (Fig.3) will die when exposed to 
1% SDS, but can potentially survive in less (Fig.1).
Potential types of suppression mutation
Intragenic mutation
• Same site replacement: a form of suppression wherein the 
originally mutated gene is simply mutated back to N2.
• Compensatory second site mutation: a mutation 
elsewhere on the protein that affects it in such a way that 
the original mutation’s phenotype is reduced. Rare.
Extragenic
• Bypass suppression: a mutation that activates an alternate 
pathway, “bypassing” the defective components. 
o For example, a mutation in a non-coding region that 
results in a change in the level of dex-1 expression.
• Suppression by interacting components: a mutation that 
restores an abnormal protein to proper functionality by 
changing an interacting protein.5
o For example, the CUT protein is an interactor with the 
DEX-1 protein, so a change in it could potentially cause a 
suppression by interacting components.
Further Research
Mapping a Gene:
• With the exact mutation site found, we can track the 
gene’s resulting protein’s pathway and determine what 
kind of suppression it is.
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Fig.5 Protocol for EMS mutagenesis3
Mutating the worms:
• We synced worms up at 
the L4 stage (Fig.4)
• Mutated synced L4’s with 
Ethyl Methanosulfonate
o We were sure to use 
proper safety equipment, 
as EMS is toxic
• Checking every day and 
separating individuals 
when needed, we 
allowed the mutated P0 
generation to lay the F1 
generation, then we let 
those F1 lay the F2 
(which are able to have 
recessive phenotypes).3
• For this reason, these F2 
are the worms we 
screened with SDS.
Fig.4 dex-1 L4 worm. Closeup of vulva.
Screening the worms:
• Got F2 gen to become 
dauers
o We did this by placing 
adults older than L1 at 
25oC. This causes their 
offspring to reach dauer
thanks to a secondary 
mutation in our worms 
known as daf-7 
• Exposed the dauer F2 to 
SDS
• Picked survivors onto 
their own plates
• From here we can move 
onto gene mapping
Fig.6 Protocol for a suppressor screen.4
Fig.1 SDS sensitivity scale.
AGA CCC CGA CCA             (N2 protein)
AGA CCC TGA CCA            (dex-1 protein)2
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Fig.2 N2 dauer
Fig.3 dex-1 dauer
